Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA

Kuros Biosciences, a leader in next generation bone graft technologies, announced results from two prospective, randomized clinical studies – the STRUCTURE and MAXA trials.